X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
folfirinox (504) 504
pancreatic cancer (371) 371
gemcitabine (326) 326
index medicus (306) 306
chemotherapy (291) 291
oncology (275) 275
humans (251) 251
cancer (223) 223
survival (209) 209
adenocarcinoma (203) 203
male (165) 165
female (164) 164
aged (159) 159
pancreatic neoplasms - drug therapy (159) 159
middle aged (146) 146
pancreatic neoplasms - pathology (137) 137
metastasis (127) 127
surgery (125) 125
antineoplastic combined chemotherapy protocols - therapeutic use (123) 123
nab-paclitaxel (106) 106
treatment outcome (103) 103
therapy (101) 101
adult (91) 91
gastroenterology & hepatology (91) 91
neoadjuvant therapy (88) 88
care and treatment (87) 87
retrospective studies (77) 77
deoxycytidine - analogs & derivatives (76) 76
pancreatic neoplasms - mortality (73) 73
analysis (70) 70
oxaliplatin (69) 69
patients (69) 69
prognosis (69) 69
resection (69) 69
phase-iii trial (66) 66
adenocarcinoma - drug therapy (65) 65
medicine & public health (65) 65
cancer therapies (64) 64
trial (63) 63
camptothecin - analogs & derivatives (62) 62
fluorouracil - administration & dosage (62) 62
aged, 80 and over (57) 57
chemoradiotherapy (57) 57
irinotecan (56) 56
pancreatic neoplasms - surgery (55) 55
leucovorin - administration & dosage (52) 52
medical prognosis (51) 51
neoplasm staging (51) 51
organoplatinum compounds - administration & dosage (51) 51
camptothecin - administration & dosage (50) 50
deoxycytidine - administration & dosage (50) 50
antineoplastic combined chemotherapy protocols - adverse effects (49) 49
ductal adenocarcinoma (49) 49
pancreatic neoplasms - therapy (48) 48
usage (48) 48
adenocarcinoma - pathology (45) 45
research (45) 45
survival rate (43) 43
carcinoma (42) 42
clinical trials (42) 42
disease-free survival (42) 42
chemoradiation (41) 41
health aspects (40) 40
pharmacology & pharmacy (40) 40
pancreatic adenocarcinoma (39) 39
radiotherapy (39) 39
pancreaticoduodenectomy (38) 38
toxicity (38) 38
paclitaxel plus gemcitabine (37) 37
pancreatectomy (37) 37
survival analysis (37) 37
tumors (37) 37
antineoplastic combined chemotherapy protocols - administration & dosage (36) 36
drug therapy (36) 36
5-fluorouracil (35) 35
adenocarcinoma - mortality (35) 35
adjuvant chemotherapy (35) 35
deoxycytidine - therapeutic use (35) 35
outcomes (35) 35
patient outcomes (35) 35
fluorouracil (34) 34
kaplan-meier estimate (34) 34
metastases (34) 34
phase-ii (34) 34
abridged index medicus (33) 33
adjuvant treatment (32) 32
folinic acid (32) 32
neoplasm metastasis (32) 32
adenocarcinoma - surgery (31) 31
medical research (31) 31
metastatic pancreatic cancer (31) 31
neoplasms. tumors. oncology. including cancer and carcinogens (31) 31
carcinoma, pancreatic ductal - drug therapy (30) 30
carcinoma, pancreatic ductal - pathology (30) 30
follow-up studies (30) 30
pancreatic ductal adenocarcinoma (30) 30
efficacy (29) 29
mortality (29) 29
plus gemcitabine (29) 29
antineoplastic agents - therapeutic use (27) 27
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (530) 530
German (13) 13
Japanese (6) 6
French (5) 5
Czech (2) 2
Chinese (1) 1
Italian (1) 1
Korean (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


British Journal of Surgery, ISSN 0007-1323, 08/2019, Volume 106, Issue 9, pp. 1257 - 1257
Journal Article
Clinical Cancer Research, ISSN 1078-0432, 09/2018, Volume 24, Issue 17, pp. 4154 - 4161
Purpose: Various genetic driver aberrations have been identified among distinct anatomic and clinical subtypes of intrahepatic and extrahepatic... 
RESISTANCE | MODIFIED FOLFIRINOX | MUTATIONS | EFFICACY | ONCOLOGY | SAFETY
Journal Article
British Journal of Cancer, ISSN 0007-0920, 09/2015, Volume 113, Issue 7, pp. 989 - 995
Journal Article
HPB, ISSN 1365-182X, 09/2019, Volume 21, Issue 9, pp. 1250 - 1250
Journal Article
American Journal of Clinical Oncology: Cancer Clinical Trials, ISSN 0277-3732, 2017, Volume 40, Issue 6, pp. 552 - 554
Journal Article
Asian Pacific Journal of Cancer Prevention, ISSN 1513-7368, 2015, Volume 16, Issue 14, pp. 6001 - 6006
Journal Article
International journal of molecular sciences, ISSN 1422-0067, 09/2019, Volume 20, Issue 18, p. 4504
Pancreatic ductal adenocarcinoma (PDAC), generally known as pancreatic cancer (PC), ranks the fourth leading cause of cancer-related deaths in the western... 
pancreatic cancer | FOLFIRINOX | chemoresistance | gemcitabine | PDAC
Journal Article
CANCER CHEMOTHERAPY AND PHARMACOLOGY, ISSN 0344-5704, 06/2018, Volume 81, Issue 6, pp. 1017 - 1023
We evaluated the efficacy and safety of a modified FOLFIRINOX regimen for chemotherapy-na < ve patients with metastatic pancreatic cancer. Patients with... 
FOLFIRINOX | LEUCOVORIN | Modified FOLFIRINOX | OXALIPLATIN | GEMCITABINE | BREAST-CANCER | TRIAL | Chemotherapy | CABAZITAXEL | ONCOLOGY | Pancreatic cancer | COLORECTAL-CANCER | PHARMACOLOGY & PHARMACY | Metastatic | RESISTANT PROSTATE-CANCER | JAPANESE PATIENTS
Journal Article
Journal Article
Japanese Journal of Gastroenterological Surgery, ISSN 0386-9768, 2017, Volume 50, Issue 6, pp. 454 - 460
Journal Article
Journal Article
Cancer Chemotherapy and Pharmacology, ISSN 0344-5704, 6/2018, Volume 81, Issue 6, pp. 1017 - 1023
We evaluated the efficacy and safety of a modified FOLFIRINOX regimen for chemotherapy-naïve patients with metastatic pancreatic cancer.Patients with untreated... 
Chemotherapy | FOLFIRINOX | Medicine & Public Health | Pancreatic cancer | Oncology | Cancer Research | Modified FOLFIRINOX | Metastatic | Pharmacology/Toxicology | Cancer patients | Oncology, Experimental | Research | Metastasis | Cancer | Slopes | Intravenous administration | Disease control | Survival | Patients | Metastases | Incidence | Confidence intervals | Infusion | Irinotecan | Oxaliplatin | Safety | Neutropenia
Journal Article
Journal of Gastrointestinal Cancer, ISSN 1941-6628, 2018
Advanced pancreatic adenocarcinoma (PA) is an aggressive disease that has poor prognosis and frequently interferes with patient's quality of life. There has... 
Second-line treatment | FOLFIRINOX | Gemcitabine | Pancreatic
Journal Article
Revista Medica de Rosario, ISSN 0327-5019, 05/2018, Volume 84, Issue 2, pp. 67 - 70
Journal Article
American Journal of Clinical Oncology: Cancer Clinical Trials, ISSN 0277-3732, 03/2019, Volume 42, Issue 3, pp. 243 - 246
Journal Article
CLINICAL CANCER RESEARCH, ISSN 1078-0432, 08/2019, Volume 25, Issue 16, pp. 4973 - 4984
Purpose: In research settings, circulating tumor DNA (ctDNA) shows promise as a tumor-specific biomarker for pancreatic ductal adenocarcinoma (PDAC). This... 
SURVIVAL | CTDNA | FOLFIRINOX | THERAPY | ONCOLOGY | ADENOCARCINOMA | MUTATIONS | GEMCITABINE | BLOOD | Index Medicus
Journal Article
Cancer Research, ISSN 0008-5472, 2019, Volume 79, Issue 9, pp. 2327 - 2338
When pancreatic cancer cannot be removed surgically, patients frequently experience morbidity and death from progression of their primary tumor. Radiation... 
FOLFIRINOX | HIF-2-ALPHA | THERAPY | METASTASIS | ROXADUSTAT | ONCOLOGY | ADENOCARCINOMA | PHASE-II | ALPHA | TUMORS | GEMCITABINE
Journal Article
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.